invivo therapeutics stock price target

InVivo Therapeutics Announces Closing of 30 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Wednesday 15 April 2020. A high-level overview of InVivo Therapeutics Holdings Corp.

Nviv Invivo Therapeutics Holdings Corp Stock Overview U S Nasdaq Barron S

Given the investment horizon of 90 days the next forecastedpress releasewill be in about 8 days.

. That means the average analyst price target for NVIV stock is 93750. In depth view into InVivo Therapeutics Holdings Price Target including historical data from 2013 charts stats and industry comps. NVIV analyst rating is Strong Buy.

InVivo Therapeutics has a beta of 129 indicating that its stock price is 29 more volatile than the SP 500. On the other hand Invivo Therapeutics target price is what analysts think the stock is worth or could sell for in the future. News InVivo Therapeutics Holdings Corp.

That means the average analyst price target for NVIV stock is 3750. NVIV stock price quote with breaking news financials statistics charts and more. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

Ad Horizon Is A Leading High-Growth Biopharma Company. Net Loss for the year was 989 M with profit before overhead payroll taxes and interest of 0. 36200 - 39600 InVivo Therapeutics 36200 -02800 -718 General Chart News Analysis Financials Technical Forum Technical Analysis.

Analyst Estimates Rating WSJ InVivo Therapeutics Holdings Corp. Invivo Therapeutics Holdings Corps variance in analysts estimates is less than almost 100 of all US stocks. NVIV IEX Real-Time Price USD.

The prediction is based on 1 analyst estimates. The low price target for NVIV is 93750 while the high price target is 93750. No significant news for NVIV in the past two years.

Key Stock Data PE Ratio TTM NA EPS TTM -754 Market Cap. In depth view into InVivo Therapeutics Holdings Price Target Upside Daily including historical data from 2013 charts stats and industry comps. InVivo Therapeutics Holdings Corp.

That means the average analyst price target for NVIV stock is 3750. The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 93750 with a high estimate of 93750 and a. Risk Volatility.

312 PM EDT 071222 Open 3735 Prior Close 375 071122 1. NVIV InVivo Therapeutics Holdings Corp. Invivo Therapeutics current and.

Invivo Therapeutics Holdings Corp. Based on NVIV analyst price targets NVIV stock forecast is 93750 for a year from now. NVIV has a higher upside potential average analyst target price relative to current price than 9961 of Healthcare stocks.

Find the latest InVivo Therapeutics Holdings Co NVIV analyst stock forecast price target and recommendation trends with in-depth analysis from research. Invivo Therapeutics Holdings Corps variance in analysts estimates is less than almost 100 of all US stocks. The volatility of related hype on Invivo Therapeutics is about 00 with expected price after next announcement by competition of 406.

Based on analysts offering 12 month price targets for NVIV in the last 3 months. Invivo Therapeutics current and average target prices are 397 and 3754 respectively. The current price of Invivo Therapeutics is the price at which Invivo Therapeutics Holdings is currently trading.

The low price target for NVIV is 3750 while the high price target is 3750. Invivo Therapeutics is now traded for 439. Comparatively Artivion has a.

Get a real-time Invivo Therapeutics Holdings Corp. NVIV IEX Real-Time Price USD. NVIV has a greater average analyst price target than 7821 of stocks in the small market cap category.

Invivo Therapeutics Holdings Corp Common Stock Nviv Stock Price Quote News History Nasdaq